GB:POLB Stock Latest News
Company AnnouncementsPoolbeg bolsters POLB 001 patent protection with South Korean grant3w ago
Company AnnouncementsPoolbeg Pharma advances POLB 001 and extends cash runway with 2026 interim results1M ago- Company AnnouncementsPoolbeg advances POLB 001 CRS trial with steady patient recruitment1M ago
Company AnnouncementsPoolbeg cleared to press ahead with POLB 001 trial after positive safety review1M ago
Company AnnouncementsPoolbeg Pharma to spotlight POLB 001 at global scientific and investor conferences1M ago
Company AnnouncementsPoolbeg Pharma Wins Israeli Patent Allowance for Key Cancer Immunotherapy Asset3M agoCompany AnnouncementsPoolbeg Pharma Begins POLB 001 Trial, Targets Major CRS Market Opportunity3M ago
Company AnnouncementsPoolbeg Pharma strengthens POLB 001 patent protection in South Africa4M ago- Company AnnouncementsPoolbeg Wins Key European Patent for Lead Cancer Immunotherapy Asset4M ago
Company AnnouncementsPoolbeg Pharma Restructures Executive Chair’s Indirect Holding with No Change in Beneficial Stake4M ago
Company AnnouncementsPoolbeg’s POLB 001 Data Points to Wider Cancer Use and Safer Immunotherapy4M ago
Company AnnouncementsPoolbeg Pharma hits key milestone as POLB 001 trial site activated and recruitment begins4M agoCompany AnnouncementsPoolbeg Pharma AGM Resolutions Passed and Registered Office Moved to London4M ago
Company AnnouncementsPoolbeg Wins FDA Backing on Development Path for Lead Cancer Support Drug5M ago
- Company AnnouncementsPoolbeg Pharma Signals Momentum Ahead of 2026 Data5M ago
Company AnnouncementsPoolbeg to Showcase POLB 001 CRS Data at Major Hematology Congress5M ago
Company AnnouncementsPoolbeg Pharma Wins Canadian Patent for POLB 001 in Cancer CRS Prevention5M ago
Company AnnouncementsPoolbeg Pharma Publishes 2025 Annual Report and Sets June AGM Date5M ago
Company AnnouncementsPoolbeg Pharma Signals Momentum Ahead of 2026 Data6M agoCompany AnnouncementsPoolbeg Pharma advances POLB 001 and obesity pipeline on solid 2025 funding base6M ago
Company AnnouncementsPoolbeg wins UK trial clearance as POLB 001 tipped for multi‑billion‑dollar CRS market6M ago